Subtyping atypical eosinophilic renal cell tumours through integrated morphological, immunohistochemical, and mutational characters

Read full text Summarise with VIRAT
Authors: Shan Zheng, Jie Zuo, Manxiang Chen, Tian Han, Lina Gao, Tieliang Pang, Lei Guo, Jing Liang, Zitong Feng, Zhiyi Zhang, Jianzhong Shou, Jianming Ying
Cited by: 0
References: 58

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Introducing molecular features into diagnostic criteria in the WHO Classification of Renal Tumours, Fifth Edition (2022), significantly improves the discrimination between morphologically similar neoplasms. Renal cell tumours with eosinophilic cytoplasm often exhibit overlapping histological features, making the differential diagnoses challenging. METHODS: In this retrospective study, we investigated 16 cases of atypical eosinophilic renal cell tumours (ATERCT), with four renal oncocytoma (RO) and three classic chromophobe renal cell carcinomas (chRCC) as controls. Morphology, immunohistochemistry (IHC), special staining and whole-exome sequencing (WES) were employed to facilitate the subtyping of these cases. RESULTS: Based on histomorphological features (tumour growth pattern and nuclear morphology), IHC markers (CK7, CK20, CD117, and mTOR) and special colloidal iron staining, 7 cases were classified including 2 eosinophilic chRCC, 2 RO, 1 eosinophilic vacuolated tumour (EVT), 1 eosinophilic solid and cystic renal cell carcinoma (ESC RCC) and 1 low-grade eosinophilic tumour (LOT).The gene mutational profiles by WES confirmed 5 of the 7 cases with marker gene mutations, and suggested the pathological types of 6 cases in the remaining 9 cases, which left 3 cases unresolved. The landscape of mutational profiling demonstrated an individual-specific pattern in the 23 patients that no single mutation definitively distinguished among RO, eosinophilic chRCC, LOT, EVT, or ESC RCC. A panel covering 69 mutations from 34 genes could segregate the 23 patients into 6 distinct groups by consensus clustering analysis. By integrating morphological, IHC, special staining and mutational features, we found a combination of characters of FGFR1 p.D44del / microscopic tumour borders / solid nest flakes / nucleomorphs / CD117 might represent the strongest power of subtyping the 16 patients by a L1-regularized supportive virtual machine algorithm. CONCLUSIONS: These findings indicated that genetic mutations were diverse among eosinophilic renal cell tumours and particular mutations might facilitate the differential diagnosis. The integration of morphological, IHC, special staining and mutational features could enhance subtyping diagnostically challenging eosinophilic ATERCT.

Fields of Study & Subjects

Renal cell carcinoma treatment Cancer Genomics and Diagnostics Adrenal and Paraganglionic Tumors

Publication details

Journal / source
BMC Cancer
Volume
26
Issue
1
Publication date
25 March 2026
Language
EN